Soo Aleman, MD, PhD

Department of Infectious Diseases, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden, Sweden

Disclosure(s): AbbVie: Grant/Research Support, Honoraria; Biogen: Honoraria; Gilead Sciences, Inc.: Grant/Research Support, Honoraria; MSD: Honoraria

Poster(s):

• (P-2191) Efficacy and safety of buleviritide monotherapy for chronic hepatitis D in patients with and without cirrhosis: results from the week 144 interim analysis of a phase 3 randomized study
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT